Neoadjuvant Therapy Helps Shape Changing Landscape of Early-Stage NSCLC
The treatment of patients with early-stage non–small cell lung cancer is rapidly evolving across the spectrum of care, particularly in the neoadjuvant setting, where evidence in favor of systemic chemoimmunotherapy regimens is growing.